William Blair initiates coverage of digital finance stocks

William Blair initiates coverage of digital finance stocks with an Outperform on SoFi, Affirm
SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the digital finance subsegment of fintech with an Outperform rating on the two stocks.
Sterling Infrastructure initiated with an Outperform at William Blair
William Blair last night initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating. Sterling’s “industry-leading” data
Denali Therapeutics’ (DNLI) Outperform Rating Reiterated at William Blair
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report published on Wednesday,RTT News reports. Other equities research analysts also recently issued research reports about the company.
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and conservative guidance. The investment firm noted that after several "solid" quarters following a Q1 2024 miss and turnover in its sales force,
SoFi Technologies initiated with an Outperform at William Blair
William Blair analyst Andrew Jeffrey initiated coverage of SoFi Technologies (SOFI) with an Outperform rating and no price target The firm
Affirm, SoFi Initiated At Outperform In Consumer Digital Financing
William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.
William Blair downgrades Enfusion (ENFN) to a Hold
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
Research Analysts Offer Predictions for Affirm Q2 Earnings
Research analysts at William Blair issued their Q2 2025 EPS estimates for shares of Affirm in a research report issued to ...
24/7 Wall St1d
SoFi Technologies (SOFI) Price Prediction and Forecast 2025-2030
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
bovnews18h
What’s Driving Tenaya Therapeutics Inc (TNYA) Stock’s -51.39% Plunge Over the Past Month?
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
Morningstar1mon
William Blair Small-Mid Cap Growth N
William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from its parent firm's long-term risk-adjusted performance, as shown by the firm's average ...
FierceBiotech3d
Neumora's dig into phase 3 depression data disappoints analysts
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
bovnews9h
What’s Fueling Generation Bio Co (GBIO) Stock’s -61.35% Loss Below Its 200-Day SMA?
On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...
Yahoo Finance11d
William Blair Names Stewart Licudi Head of European Investment Banking
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
FY2024 EPS Estimates for Moderna Increased by William Blair
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...